JAIN, A. Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management. Canadian Diabetes & Endocrinology Today, [S. l.], v. 3, n. s01, p. 2–8, 2025. DOI: 10.58931/cdet.2025.3s0144. Disponível em: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/3-s01-Jain. Acesso em: 17 feb. 2026.